Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter
- 25 January 1996
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 77 (3), 53A-59A
- https://doi.org/10.1016/s0002-9149(97)89118-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillationJournal of the American College of Cardiology, 1992
- Management of Atrial FibrillationNew England Journal of Medicine, 1992
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboNew England Journal of Medicine, 1991
- Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.Circulation, 1990
- Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugsThe American Journal of Cardiology, 1990
- Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.Circulation, 1989
- Comparison of encainide and quinidine for supraventricular tachyarrhythmiasThe American Journal of Cardiology, 1988
- Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatmentThe American Journal of Cardiology, 1988
- Summary of efficacy and safety of flecainide for supraventricular arrhythmiasThe American Journal of Cardiology, 1988
- Quinidine SyncopeCirculation, 1964